Intracellular Calcium Regulated NHE3 Endocytosis
细胞内钙调节 NHE3 内吞作用
基本信息
- 批准号:8268139
- 负责人:
- 金额:$ 8.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAgonistApicalBrush BorderCalciumCarbacholCarrier ProteinsCell membraneCell modelCellsChlorpromazineCholesterolClathrinConfocal MicroscopyCyclic AMPCytotoxinDataDiarrheaDigestionDimensionsDiseaseEndocytic VesicleEndocytosisEndocytosis PathwayEndosomesEpithelial CellsEventExhibitsExocytosisGastrointestinal tract structureHelicobacter pyloriImageImaging TechniquesIn VitroInflammatory Bowel DiseasesIntegral Membrane ProteinIntestinesLeadLifeLocationMediatingMembrane MicrodomainsMonomeric GTP-Binding ProteinsMorphologyMuscarinic M3 ReceptorPathway interactionsPlayProcessProteinsRecyclingRegulationResearch DesignResolutionRoleRotavirus InfectionsShapesSmall IntestinesSodiumStructureSurfaceSymptomsTechniquesTechnologyTestingTherapeuticabsorptionapical membranebasolateral membranecholinergicdesignfolate-binding proteinileumin vivoinhibitor/antagonistinsightnovelpolarized cellpreventresponserho GTP-Binding Proteinssmall hairpin RNAtrafficking
项目摘要
DESCRIPTION (provided by applicant): In the gastrointestinal (GI) tract, electroneutral Na+ absorption is regulated during the postprandial state as part of the neurohumoral response in digestion. Regulation of the intestinal brush border (BB) Na+/H+ exchanger, NHE3, accounts for most of the recognized digestion related changes in neutral Na+ absorption, as well as most of the inhibition of Na+ absorption that occurs in diarrheal diseases. NHE3 is regulated by changes in its plasma membrane versus intracellular location as a result of alterations in the rates of endocytosis and/or exocytosis. In the small intestine, elevation of intracellular calcium ([Ca2+]i) by carbachol (mimics postprandial changes due to cholinergic activation) inhibits NHE3 activity by 40% and similarly decreases NHE3 surface expression. However, the mechanisms responsible for [Ca2+]i regulated NHE3 trafficking in intestinal epithelial cells are not well understood. Therefore, the long-term objective of the current study is to establish the endocytic pathway that regulates NHE3 activity under elevated [Ca2+]i conditions which occur during normal digestion as well as during diarrheal diseases (e.g. rotavirus infection). The current proposal will attempt to identify whether clathrin-independent endocytosis contributes to the trafficking of an important regulator of electroneutral sodium absorption in intestinal epithelial cells. SPECIFIC AIMS: We propose to test the hypothesis that (1) inhibition of clathrin-mediated endocytosis (CME) prevents constitutive, but not carbachol-mediated, endocytosis of NHE3, and (2) carbachol-mediated endocytosis of NHE3 occurs through a lipid raft, activated Cdc42-dependent pathway that does not involve clathrin. Our concept that NHE3 endocytosis may occur through multiple endocytic pathways is novel and our current proposal will be the first to separate NHE3 endocytosis into clathrin-dependent and clathrin- independent pathways. We propose to use advanced imaging techniques including spinning disk confocal microscopy to characterize NHE3 endocytosis in four dimensions in live Caco-2BBe cells (polarized intestinal epithelial cell model) as well as shRNA knockdown technology to quantitate the critical components of clathrin- independent endocytosis, including Cdc42. SIGNIFICANCE: The use of advanced imaging will not only define how NHE3 endocytosis occurs but could also establish a new technique for studying the trafficking of other transport proteins, particularly those that exist in the apical domain of epithelial cells. Evaluating the mechanisms responsible for the regulation of NHE3 activity by elevated [Ca2+]i should contribute to an understanding of a mechanism responsible for diarrheal diseases that result from decreased NHE3 activity and reduced sodium absorption. Furthermore, establishing a role for clathrin-independent endocytosis in elevated [Ca2+]i regulation of intestinal transporters could provide important information in early events of transport protein regulation that could lead to alternate therapeutic strategies for treating acute diarrheal symptoms in diseases including rotavirus infection, inflammatory bowel disease, or congenital sodium diarrhea.
描述(由申请方提供):在胃肠道(GI)中,餐后状态期间电中性Na+吸收作为消化中神经体液反应的一部分受到调节。肠刷状缘(BB)Na+/H+交换器NHE 3的调节解释了大多数公认的中性Na+吸收的消化相关变化,以及大多数在消化性疾病中发生的Na+吸收抑制。NHE 3受其质膜相对于细胞内位置的变化调节,这是内吞和/或胞吐速率改变的结果。在小肠中,卡巴胆碱引起的细胞内钙([Ca 2 +]i)升高(模拟胆碱能激活引起的餐后变化)抑制NHE 3活性40%,并类似地降低NHE 3表面表达。然而,负责[Ca 2 +]i调节肠上皮细胞中NHE 3运输的机制还不清楚。因此,本研究的长期目标是建立内吞途径,该途径在正常消化过程中以及腹泻疾病(例如轮状病毒感染)期间发生的[Ca 2 +]i升高条件下调节NHE 3活性。目前的建议将试图确定是否网格蛋白独立的内吞作用有助于运输的一个重要的调节剂的电中性钠吸收在肠上皮细胞。具体目标:我们建议检验以下假设:(1)抑制网格蛋白介导的内吞作用(CME)可阻止NHE 3的组成性内吞作用,但不能阻止卡巴胆碱介导的内吞作用;(2)卡巴胆碱介导的NHE 3内吞作用通过脂筏、激活的Cdc 42依赖性途径(不涉及网格蛋白)发生。我们认为NHE 3内吞作用可能通过多种内吞途径发生的概念是新颖的,我们目前的建议将是第一个将NHE 3内吞作用分为网格蛋白依赖性和网格蛋白非依赖性途径的建议。我们建议使用先进的成像技术,包括旋转盘共聚焦显微镜来表征NHE 3内吞作用在活的Caco-2BBe细胞(极化肠上皮细胞模型)中的四个维度,以及shRNA敲低技术来定量网格蛋白非依赖性内吞作用的关键组分,包括Cdc 42。重要性:使用先进的成像技术不仅可以确定NHE 3内吞作用是如何发生的,而且还可以建立一种新的技术来研究其他转运蛋白的运输,特别是那些存在于上皮细胞顶端结构域的转运蛋白。评估负责通过升高[Ca 2 +]i调节NHE 3活性的机制应有助于理解负责由NHE 3活性降低和钠吸收减少引起的结肠炎疾病的机制。此外,确定网格蛋白非依赖性内吞作用在肠道转运蛋白[Ca 2 +]i调节升高中的作用,可以为转运蛋白调节的早期事件提供重要信息,这可能导致用于治疗包括轮状病毒感染、炎性肠病或先天性钠腹泻在内的疾病的急性腹泻症状的替代治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas Constantine Zachos其他文献
Nicholas Constantine Zachos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas Constantine Zachos', 18)}}的其他基金
FASEB SRC: The Gastrointestinal Tract XIX Conference: Making and Breaking a Gut
FASEB SRC:胃肠道第十九次会议:肠道的形成和破坏
- 批准号:
10539805 - 财政年份:2022
- 资助金额:
$ 8.2万 - 项目类别:
Intracellular Calcium Regulated NHE3 Endocytosis
细胞内钙调节 NHE3 内吞作用
- 批准号:
8094691 - 财政年份:2011
- 资助金额:
$ 8.2万 - 项目类别:
PLCgamma regulates HNE3 activity through direct binding and dynamic complexes
PLCgamma 通过直接结合和动态复合物调节 HNE3 活性
- 批准号:
7920788 - 财政年份:2008
- 资助金额:
$ 8.2万 - 项目类别:
PLCgamma regulates HNE3 activity through direct binding and dynamic complexes
PLCgamma 通过直接结合和动态复合物调节 HNE3 活性
- 批准号:
7852100 - 财政年份:2008
- 资助金额:
$ 8.2万 - 项目类别:
PLCgamma regulates HNE3 activity through direct binding and dynamic complexes
PLCgamma 通过直接结合和动态复合物调节 HNE3 活性
- 批准号:
7588453 - 财政年份:2008
- 资助金额:
$ 8.2万 - 项目类别:
PLCgamma regulates HNE3 activity through direct binding and dynamic complexes
PLCgamma 通过直接结合和动态复合物调节 HNE3 活性
- 批准号:
8131791 - 财政年份:2008
- 资助金额:
$ 8.2万 - 项目类别:
相似海外基金
Elucidation of acute poisoning mechanism due to abuse of CB1 receptor agonist.
阐明滥用 CB1 受体激动剂引起的急性中毒机制。
- 批准号:
21K17323 - 财政年份:2021
- 资助金额:
$ 8.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of acute poisoning mechanism due to abuse of CB1 receptor agonist.
阐明滥用 CB1 受体激动剂引起的急性中毒机制。
- 批准号:
19K19485 - 财政年份:2019
- 资助金额:
$ 8.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Tissue repair effect in acute myocardial infarction through mobilization of endogenous Muse cells by sphingosine-1-phosphate receptor 2 agonist
1-磷酸鞘氨醇受体2激动剂动员内源性Muse细胞对急性心肌梗死的组织修复作用
- 批准号:
18K15843 - 财政年份:2018
- 资助金额:
$ 8.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6115624 - 财政年份:1998
- 资助金额:
$ 8.2万 - 项目类别:
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6219539 - 财政年份:1998
- 资助金额:
$ 8.2万 - 项目类别:
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6276858 - 财政年份:1997
- 资助金额:
$ 8.2万 - 项目类别:
ACUTE CHRONIC HORMONAL CHANGES WITH LHRH-AGONIST THERAPY
LHRH 激动剂治疗引起的急性慢性荷尔蒙变化
- 批准号:
6250152 - 财政年份:1997
- 资助金额:
$ 8.2万 - 项目类别:
ACUTE CHRONIC HORMONAL CHANGES WITH LHRH-AGONIST THERAPY
LHRH 激动剂治疗引起的急性慢性荷尔蒙变化
- 批准号:
6279945 - 财政年份:1997
- 资助金额:
$ 8.2万 - 项目类别:
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6246787 - 财政年份:1997
- 资助金额:
$ 8.2万 - 项目类别:
PSYCHOPHARMACOLOGY OF DA AGONIST CNS EFFECTS: ACUTE AND CHRONIC STUDIES
DA 激动剂中枢神经系统影响的精神药理学:急性和慢性研究
- 批准号:
3891471 - 财政年份:
- 资助金额:
$ 8.2万 - 项目类别:














{{item.name}}会员




